Home / World Marketplace / Archive by category Global Health & Biotech (Page 29)

Archive by category Global Health & Biotech

Boehringer Ingelheim announces succession Chairmen Shareholders’ Committee and Board of Managing Directors

Christian Boehringer to hand over as Chairman of the Shareholders’ Committee to Hubertus von Baumbach Shashank Deshpande, Member of the Board of Managing Directors, to succeed Hubertus von Baumbach as Chairman of the Board of Managing Directors Appointments to be effective July 1, 2025 The Shareholders’ Committee of Boehringer Ingelheim have announced the following appointments in the Shareholders’ Committee and [...]

Biosidus Announces Promising Interim Results from Phase III Study on Agalsidase Beta for Fabry Disease

BUENOS AIRES, Argentina, April 16, 2025 (Korea Bizwire) – Biosidus, an Argentinean pioneer company in biotechnology research, development, and the production of high-quality biosimilars, has announced encouraging interim results from the Phase III SMILE1 study. After 26 weeks of treatment, the study successfully met its primary endpoint, underscoring the potential of agalsidase beta as a safe and effective biosimilar treatment for Fabry [...]

Ascom Annual General Meeting approves all proposals of the Board of Directors

Ad hoc announcement pursuant to Art. 53 LR Baar, Switzerland, April 16, 2025 At the Annual General Meeting held on April 16, 2025, in Zug, the shareholders of Ascom Holding AG approved by a large majority all proposals presented by the Board of Directors. 54 shareholders attended the Annual General Meeting. In total, 20’238’079 registered [...]

Sabin Begins Marburg Vaccine Trial in U.S

WASHINGTON, April 16, 2025 (Korea Bizwire) — The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, administering doses to the first participants in Melbourne, Florida. This trial builds on ongoing Phase 2 testing in Kenya and Uganda, with initial findings from that research expected [...]

Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG

All proposals of Board of Directors approved Gilbert Ghostine re-elected as Chairman of Board of Directors; all other Board members standing for re-election confirmed Dividend of CHF 0.60 per registered dividend-paying share approved, representing 24% of core net income Basel, April 15, 2025 (Korea Bizwire) – Sandoz (SIX:SDZ;OTCQX:SDZNY) today announced that its shareholders approved all proposals [...]

Boehringer Ingelheim and Cue Biopharma partner to develop next-generation treatment for autoimmune and inflammatory diseases

Partnership bolsters Boehringer’s autoimmune and inflammatory disease pipeline portfolio aiming to tackle areas of high unmet patient need. The agreement focuses on further research and development of a novel, first-in-class bispecific compound for T cell mediated targeted depletion of specific B cells to address autoimmune and inflammatory diseases. The candidate compound has the potential to [...]

Cancer Treatment Revolutionized by Cellular Engineering, and Nanotechnology Redefined by Carbon Nanotubes: Success of Scientists from Canada & Japan Honored by King Faisal Prize

Riyadh, Saudi Arabia, April 14, 2025 (Korea Bizwire) – During the 47th session of the King Faisal Prize on April 14, exceptional accomplishments in the fields of cellular engineering and nanotechnology were honored. Professor Michel Sadelain was awarded the Medicine Prize for his groundbreaking contributions to Chimeric Antigen Receptor (CAR) T-cell therapy, a revolutionary cancer [...]

[Corrected] Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules – corrected: reference to date of product launch in Europe removed; link to “Important Safety Information” updated Company aims to accelerate access to much-needed biosimilar to reference medicine Enbrel®* for US patients with disabling inflammatory diseases Despite FDA approval nearly a decade ago, [...]

Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Company aims to accelerate access to much-needed biosimilar to reference medicine Enbrel®* for US patients with disabling inflammatory diseases Despite FDA approval nearly a decade ago, etanercept biosimilar continues to be blocked Sandoz seeking damages in addition to clearing path for launch Basel, April [...]

ProstaVive Reviews (BREAKING REPORT): Must-Read Warnings, Ingredients, Benefits & Real Results Uncovered

JUPITER, Fla., April 10, 2025 (Korea Bizwire) – With prostate issues becoming an increasingly urgent concern for millions of aging men, ProstaVive has exploded onto the men’s health scene, dominating online discussions, trending across wellness platforms, and drawing the attention of medical professionals and skeptics alike. Promising to support prostate function naturally—without prescriptions, surgeries, or hormone-altering [...]